These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7813578)

  • 21. Vacuous jaw movements induced by acute reserpine and low-dose apomorphine: possible model of parkinsonian tremor.
    Salamone J; Baskin P
    Pharmacol Biochem Behav; 1996 Jan; 53(1):179-83. PubMed ID: 8848448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of chronic haloperidol and clozapine on vacuous chewing and dopamine-mediated jaw movements in rats: evaluation of a revised animal model of tardive dyskinesia.
    Ikeda H; Adachi K; Hasegawa M; Sato M; Hirose N; Koshikawa N; Cools AR
    J Neural Transm (Vienna); 1999; 106(11-12):1205-16. PubMed ID: 10651114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine.
    Hertel P; Nomikos GG; Svensson TH
    Br J Pharmacol; 1997 Dec; 122(8):1639-46. PubMed ID: 9422809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens.
    Ichikawa J; Meltzer HY
    Brain Res; 2000 Mar; 858(2):252-63. PubMed ID: 10708676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence that angiotensin II enhances apomorphine-induced jaw movements via AT1 receptors in the ventrolateral striatum: studies by magnet-sensing system in freely moving rats.
    Lee J; Adachi K; Gionhaku N; Fujita S; Uchida T; Gerstner GE; Koshikawa N
    Methods Find Exp Clin Pharmacol; 2004 Apr; 26(3):195-9. PubMed ID: 15148525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Ichikawa J; Chung YC; Li Z; Dai J; Meltzer HY
    Brain Res; 2002 Dec; 958(1):176-84. PubMed ID: 12468043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of intrastriatal injections of selective dopamine D-1 and D-2 agonists and antagonists on jaw movements of rats.
    Koshikawa N; Aoki S; Hiruta M; Tomiyama K; Kobayashi M; Tsuboi Y; Iwata K; Sumino R; Stephenson JD
    Eur J Pharmacol; 1989 Apr; 163(2-3):227-36. PubMed ID: 2566502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of muscarinic receptors in the activation of the ventral subiculum and the consequences for dopamine release in the nucleus accumbens.
    Moss S; Sharott A; Goodhead LH; Mitchell SN
    Eur J Pharmacol; 2003 Jan; 460(2-3):117-25. PubMed ID: 12559371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prefrontal, accumbal [shell] and ventral striatal mechanisms in jaw movements and non-cyclase-coupled dopamine D1-like receptors.
    Adachi K; Hasegawa M; Fujita S; Lee J; Cools AR; Waddington JL; Koshikawa N
    Eur J Pharmacol; 2003 Jul; 473(1):47-54. PubMed ID: 12877937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of amfonelic acid on the haloperidol- and clozapine-induced increase in extracellular DOPAC in the nucleus accumbens and the striatum.
    Rivest R; Marsden CA
    Synapse; 1992 Jan; 10(1):71-8. PubMed ID: 1371367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clozapine decreases neuropeptide Y-like immunoreactivity and neuropeptide Y mRNA levels in rat nucleus accumbens.
    Obuchowicz E; Turchan J
    Eur Neuropsychopharmacol; 1999 Jun; 9(4):329-35. PubMed ID: 10422894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens.
    Ichikawa J; Meltzer HY
    J Pharmacol Exp Ther; 1991 Jan; 256(1):348-57. PubMed ID: 1703232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The superior colliculus contains a discrete region involved in the control of jaw movements: role of GABAA receptors.
    Adachi K; Hasegawa M; Ikeda H; Sato M; Koshikawa N; Cools AR
    Eur J Pharmacol; 2003 Mar; 464(2-3):147-54. PubMed ID: 12620507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of clozapine on extracellular dopamine levels in the shell subregion of the rat nucleus accumbens is reversed following chronic administration: comparison with a selective 5-HT(2C) receptor antagonist.
    Shilliam CS; Dawson LA
    Neuropsychopharmacology; 2005 Feb; 30(2):372-80. PubMed ID: 15562297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mesolimbic nucleus accumbens is critically involved with the mediation of the motor inhibitory and facilitatory effects of dopamine agonists on mouse spontaneous climbing behaviour.
    Costall B; Eniojukan JF; Naylor RJ
    Eur J Pharmacol; 1983 Dec; 96(3-4):201-10. PubMed ID: 6426976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presynaptic muscarinic receptors on dopaminergic terminals in the nucleus accumbens.
    De Belleroche J; Kilpatrick IC; Birdsall NJ; Hulme EC
    Brain Res; 1982 Feb; 234(2):327-37. PubMed ID: 7059834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Li Z; Ichikawa J; Huang M; Prus AJ; Dai J; Meltzer HY
    Psychopharmacology (Berl); 2005 Dec; 183(2):144-53. PubMed ID: 16220333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; jaw movements.
    Koshikawa N; Miwa Y; Adachi K; Kobayashi M; Cools AR
    Eur J Pharmacol; 1996 Jul; 308(3):227-34. PubMed ID: 8858292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective inhibition of mesolimbic dopamine release following chronic administration of clozapine: involvement of alpha 1-noradrenergic receptors demonstrated by in vivo voltammetry.
    Lane RF; Blaha CD; Rivet JM
    Brain Res; 1988 Sep; 460(2):398-401. PubMed ID: 2852047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.